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9 Abstract Olfactory ensheathing cells (OECs) are a type of
10 glia from the mammalian olfactory system, with neuro-
11 protective and regenerative properties. b-Amyloid peptides
12 are a major component of the senile plaques characteristic
13 of the Alzheimer brain. The amyloid beta (Ab) precursor
14 protein is cleaved to amyloid peptides, and Ab25–35 is
15 regarded to be the functional domain of Ab, responsible for
16 its neurotoxic properties. It has been reported that Ab25–35
17 triggers reactive oxygen species (ROS)-mediated oxidative
18 damage, altering the structure and function of mitochon-
19 dria, leading to the activation of the mitochondrial intrinsic
20 apoptotic pathway. Our goal is to investigate the effects of
21 OECs on the toxicity of aggregated Ab25–35, in human
22 neuroblastoma SH-SY5Y cells. For such purpose, SH-
23 SY5Y cells were incubated with Ab25–35 and OEC-
24conditioned medium (OECCM). OECCM promoted the
25cell viability and reduced the apoptosis, and decreased the
26intracellular ROS and the lipid peroxidation. In the pres-
27ence of OECCM, mRNA and protein levels of antioxidant
28enzymes (SOD1 and SOD2) were upregulated. Concomi-
29tantly, OECCM decreased mRNA and the protein expres-
30sion levels of cytochrome c, caspase-9, caspase-3, and Bax
31in SH-SY5Y cells, and increased mRNA and the protein
32expression level of Bcl-2. However, OECCM did not alter
33intracellular Ca2? concentration in SH-SY5Y cells. Taken
34together, our data suggest that OECCM ameliorates
35Ab25–35-induced oxidative damage in neuroblastoma SH-
36SY5Y cells by inhibiting the mitochondrial intrinsic path-
37way. These data provide new insights into the functional
38actions of OECCM on oxidative stress-induced cell
39damage. 40
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45 Alzheimer’s disease (AD) is a progressive neurodegener-
46 ative disorder, clinically characterized by cognitive
47 decline, which includes impairment in learning, episodic
48 memory, decision making and orientation (Blennow et al.
49 2006). One of the major histopathological features of AD is
50 the accumulation of extracellular amyloid plaques that are
51 composed principally of fibrillar b-amyloid (Ab) peptide.
52 Ab is a small protein, a byproduct of amyloid precursor
53 protein (APP) processing, with Ab40 being the more fre-
54 quent isoform seen in aggregates. Specifically, Ab25–35 is
55 the key toxic fragment of the full-length Ab peptide (Ja-
56 masbi et al. 2016; Yang et al. 2016). Ab peptide aggre-
57 gation toxicity is due, among others, to oxidative injury,
58 apoptosis, mitochondrial dysfunction, disruption of sig-
59 naling pathways, and Ca2? homeostasis disturbance,
60 eventually leading to neuronal death and cognitive
61 impairment (Sun et al. 2015). Increased levels of Ab can be
62 used as an early diagnostic indicator of early preclinical
63 stage of AD (Scheff et al. 2016).
64 There is an ample body of literature supporting a crucial role
65 for mitochondrial dysfunction in AD, with altered energy
66 metabolism and reactive oxygen species (ROS) production
67 being the major correlates (Moreira et al. 2010; Lin and Beal
68 2006). It is widely believed that Ab is responsible for these
69 mitochondrial alterations, although the mechanism has not yet
70 been fully elucidated (Moreira et al. 2010). It is generally
71 accepted that Ab could elevate oxidative stress and induce
72 apoptotic cell death by initiating mitochondrial dysfunction,
73 which is associated with the changes in the proteins of Bcl-2
74 family, release of cytochrome c, and activation of caspase-3
75 (Butterfield et al. 2013).
76 Superoxide dismutase enzymes (SOD1 and SOD2) are
77 the major lines of antioxidant defense against Ab-induced
78 ROS toxicity (Yang et al. 2016). They, along with other
79 antioxidants such as metal chelators or glutathione perox-
80 idases, have been shown to be essential for neuronal sur-
81 vival and protection against oxidative damage and can be
82 used to treat cognitive and behavioral symptoms of AD
83 (Gonzalez-Zulueta et al. 1998). In addition, antioxidants
84 have been hypothesized to protect against Ab25–35-induced
85 toxicity in AD (Jung Choi et al. 2009; Fan et al. 2016).
86 Licensed treatments and examples of emerging treat-
87 ments for AD were summarized as symptomatic (choli-
88 nesterase inhibitors, NMDA receptor antagonist),
89 neuropsychiatric (atypical antipsychotics, antidepressants,
90 anticonvulsants) and disease-modifying treatments (im-
91 munotherapy, secretase inhibitors, amyloid inhibitors,
92 copper or zinc modulators, tau aggregation inhibitors,
93 GSK3 inhibitors, natural products, and vitamins) (Ballard
94 et al. 2011). However, there is no effective treatment to
95cure this disease hitherto. At present, cell transplantation
96strategy is considered as the most promising treatment
97strategy for AD (Sugaya et al. 2006; Oliveira and Hodges
982005). Mesenchymal stromal cells (Lee et al. 2009, 2012;
99Eftekharzadeh et al. 2015; Wu et al. 2007), neural pro-
100genitor cells (Zhang et al. 2015; Lee et al. 2015), and
101embryonic stem cells (Yue et al. 2015) have been used in
102the animal model of AD, and shown to obtain beneficial
103effects.
104OECs are capable of ensheathing and guiding newly
105growing axons of olfactory sensory neurons, from the
106olfactory mucosa to their targets in the CNS during
107mammalian lifespan (Moreno-Flores et al. 2003b; Wood-
108hall et al. 2001; Doucette et al. 1983; Nedelec et al. 2005).
109For this reason, many attempts to repair damage in the
110injured CNS have relied on OEC grafts (Barnett and Chang
1112004; Moreno-Flores et al. 2002; Ekberg and St John
1122014). Previous studies suggested that OEC could induce
113axonal regeneration after CNS injury and promote func-
114tional recovery in the injured spinal cord (Moreno-Flores
115and Avila 2006; Moreno-Flores et al. 2006; Garcia-Es-
116cudero et al. 2011; Li et al. 1997; Ramon-Cueto et al.
1171998, 2000). The precise mechanisms accounting for the
118observed recovery are not fully understood but may include
119neuroprotection, reduction of the glial scar, promotion of
120axonal regeneration, and remyelination (Roet and Ver-
121haagen 2014; Reginensi et al. 2015). Previously, Moreno-
122Flores et al. and other groups established immortalized
123OEC clonal cell lines, TEG3, conserving the pro-regener-
124ative capacity of primary OEC with promising potential for
125their therapeutic use (Moreno-Flores and Avila 2006;
126Pastrana et al. 2007, 2006; Garcia-Escudero et al. 2011;
127Moreno-Flores et al. 2003a, b).
128OECs produce growth factors, nerve growth factor
129(NGF), brain-derived neurotrophic factor (BDNF), glial
130cell-derived neurotrophic factor (GDNF), and ciliary neu-
131rotrophic factor (CNTF), cell adhesion molecules, and
132extracellular matrix proteins that are beneficial for axonal
133regeneration (Woodhall et al. 2001; Pellitteri et al. 2009;
134Pastrana et al. 2006). Olfactory ensheathing cell-condi-
135tioned medium (OECCM) reverts SH-SY5Y damage
136induced by 6 hydroxydopamine (6OHDA) (Shukla et al.
1372014) and astrocyte damage induced by H2O2 (Jinbo et al.
1382013; Liu et al. 2013). Furthermore, OECCM increased
139oligodendroglial and neuronal differentiation of neural
140progenitor cells (Carvalho et al. 2014) and human mes-
141enchymal stem cells (Zeng et al. 2013), respectively.
142In the present study, we show that OECCM from TEG3
143counteracts against Ab25–35-induced oxidative damage in
144SH-SY5Y cells. Analysis of mitochondrial apoptosis-re-
145lated genes allows us to propose that such effect is rendered
146via the modulation of the intrinsic apoptotic pathway.
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147 Materials and Methods
148 SH-SY5Y Cells Culture
149 SH-SY5Y cells were maintained in a humidified incubator
150 at 37 C with 5 % CO2 in Dulbecco’s Modified Eagle’s
151 Medium (DMEM) (Hyclone, Logan, UT, USA) supple-
152 mented with 10 % Fetal bovine serum (FBS) (Tian Jin Hao
153 Yang Biological Manufacture CO., Tianjin, China) and
154 1 % penicillin–streptomycin (Beyotime Biotechnology,
155 Nantong, China).
156 TEG3 Culture
157 Moreno-Flores et al. have previously described the isola-
158 tion of the immortalized clonal cell line, TEG3, which is a
159 SV40 large T antigen-stable transfectant of OEC primary
160 cultures prepared from adult rat olfactory bulbs (Moreno-
161 Flores et al. 2003a, b). TEG3 cells were maintained in
162 DMEM supplemented with 10 % FBS and 1 % penicillin–
163 streptomycin.
164 OECCM and Heat-Inactivated OECCM
165 Preparation
166 TEG3 cells were maintained in DMEM containing 10 %
167 FBS onto uncoated 25 cm2 culture flasks (Corning, New
168 York, USA) at 37 C in 5 % CO2. When the cell culture
169 reached about 80 % confluence, the conditioned medium
170 was collected, filtered through a membrane of 0.2 mm pore
171 (Jinbo et al. 2013), aliquoted and stored at -20 C. The
172 same method was used to generate the conditioned medium
173 from HeLa cells and HEK293 cells as controls, called
174 HeLaCM and HEKCM, respectively. OECCM was boiled
175 for 10 min at 100 C to generate heat-inactivated OECCM
176 (HOECCM).
177 Preparation of Aged Ab25–35 and Cell Treatment
178 As previously described by us (Yang et al. 2016), Ab25–35
179 (Sangon Biotech, Shanghai, China) was dissolved in ster-
180 ilized, double-distilled, water at a concentration of 1 mM
181 and incubated in a capped vial at 37 C for 7 days to form
182 an aggregated form. As reported in our previous study
183 (Yang et al. 2016), exposure of SH-SY5Y cells to Ab25–35
184 (40 lM) for 6 h resulted in approximately 50 % cell death.
185 SH-SY5Y cells were treated with aged 40 lM Ab25–35 and
186 OECCM for 6 h, simultaneously. The complete culture
187 medium was mixed with OECCM according to the ratio of
188 1:1 before usage. Cells cultured without any treatment were
189 used as controls.
190CCK8 Assay
191Cell viability was measured by CCK8 assay (cell counting
192kit-8, Dojindo Molecular Technologies, Tokyo, Japan).
193The SH-SY5Y cells were seeded at 1 9 104 cells per well
194in 100 ll of complete growth culture media. Cells were
195then exposed to 40 lM Ab25–35 or 40 lM Ab25–35 ?
196OECCM for 6 h. Finally, CCK-8 solution (10 ll/well)
197was added to the wells. After 2-h incubation at 37 C, the
198absorbance of each well was determined at 450 nm using a
199microplate reader.
200Detection of Apoptosis with Flow Cytometry
201Apoptosis assay kit was purchased from KeyGen Biotech-
202nology (Nanjing, China). SH-SY5Y cells were treated as
203described above, then collected after digestion with 0.25 %
204trypsin without EDTA, and washed twice with PBS (phos-
205phate buffer saline). To the pellets of SH-SY5Y cells were
206successively added 500 ll Binding Buffer, 5 ll Annexin
207V-FITC, and 5 ll Propidium iodide (PI), and then incubated
208for 10 min at room temperature in a dark environment. The
209signals of FITC and PI were detected by FL1 (FITC detector)
210and FL2 (phycoerythrin fluorescence detector) at 488 and
211561 nm, respectively, mounted on a a Beckman Gallios flow
212cytometer (Beckman Coulter, California, USA).
213Intracellular Reactive Oxygen Species (ROS) Level
214SH-SY5Y cells were treated as described above. ROS were
215detected using the cell-permeable, peroxide-sensitive flu-
216orophore (Life Technologies, USA), according to the
217manufacturer’s instructions. SH-SY5Y cells were incu-
218bated with 5 lmol/l CellROX Orange reagent for 30 min at
21937 C and then washed twice with pre-warmed PBS.
220A Beckman Gallios flow cytometer (Beckman Coulter,
221California, USA) was used to measure ROS by the fluo-
222rescence emission of the CellROX dye. The cultured cells
223were illuminated at 488 nm and emitted at 525–530 nm.
224The reported fluorescence intensity values were expressed
225as the arithmetic mean of the results ± standard deviation
226(SD), and were determined for 10,000 analyzed cells.
227Analysis of Lipid Peroxidation
228SH-SY5Y cells were treated as described above, after which
229we analyzed cell lipid peroxidation. Polyunsaturated lipids
230are susceptible to an oxidative attack, typically by ROS,
231resulting in a chain reaction with the production of end
232products such as malondialdehyde (MDA). We determined
233lipid peroxidation by quantifying the amount of cellular
234MDA via the measurement of a red-complex produced
235during the reaction of thiobarbituric acid (TBA) with MDA.
Cell Mol Neurobiol
123
Journal : Large 10571 Dispatch : 28-10-2016 Pages : 12
Article No. : 437
h LE h TYPESET











236 A microplate reader (UV-7504, Shanghai, China) was used
237 to measure the absorbance of cellular MDA at 532 nm, and
238 the MDA content was calculated according to the detailed
239 instructions of the MDA assay kit (Nanjing Jiancheng Bio-
240 engineering Institute, Nanjing, China).
241 Enzyme Activity Assays
242 SH-SY5Y cells were treated as described above for the ROS
243 level tests, after which we assayed the enzyme activity. The
244 activities of three enzymes: superoxide dismutase (SOD;
245 EC1.15.1.1), glutathione peroxidase (GPx; EC 1.11.1.9), and
246 catalase (CAT; EC1.11.1.6) were determined using com-
247 mercial kits according to the manufacturer’s protocols
248 (Nanjing Jiancheng Bioengineering Institute, Nanjing,
249 China). Enzyme activity assays were carried out using a UV–
250 Visible spectrophotometer (UV-7504, Shanghai, China).
251 Calcium Imaging
252 SH-SY5Y cells were treated as described above, and we
253 then used calcium imaging to determine intracellular free
254 Ca2? concentration ([Ca2?]i) using Fluo-4 AM (Dojindo
255 Molecular Technologies, Tokyo, Japan). In brief, the pre-
256 pared cells were loaded with the fluorescent calcium probe
257 Fluo-4 AM (5 lM) in the dark for 30 min at 37 C, washed
258 twice with PBS, and finally centrifuged at 1000 rpm for
259 3 min to remove free Fluo-4 AM. Fluo-4 AM-loaded cells
260 were resuspended and incubated for 20 min at 37 C. They
261 were then illuminated at 488 nm, and the emission light at
262 530 nm was detected.
263 Quantitative Real-Time Fluorescence Polymerase
264 Chain Reaction (q-PCR)
265 SH-SY5Y cells were treated and collected as described
266 above. Total RNA was extracted from SH-SY5Y cells with
267 Trizol reagent (TaKaRa, Tokyo, Japan). First-strand com-
268 plementary DNA (cDNA) was synthesized using the Rev-
269 erse transcription Kit (TaKaRa, Tokyo, Japan) according to
270 manufacturer’s instructions. For quantitative PCR (q-PCR),
271 10 ll reaction system including 5 ll 2 9 SYBR Green
272 (TaKaRa, Tokyo, Japan), 0.8 ll cDNA templates, and
273 0.8 ll q-PCR primers set were used. The samples were run
274 and analyzed in triplicate using CFX Connect Real-Time
275 System (Bio-Rad, Hercules, USA). The q-PCR conditions
276 were as follows: an initial 3-min denaturation step at
277 95 C, followed by the sequence of 40 cycles of 95 C for
278 5 s, 58 C for 30 s, and 72 C for 30 s. The primer sets
279 used are listed in Supplementary Table 1. Melting curve
280 analysis showed a single amplification peak for each
281 reaction. Ct values for targets were expressed as relative
282 expressions compared to the averages of housekeeping
283genes (GAPDH). The expression of each mRNA was cal-
284culated as 2DDCt .
285Western Blot
286Total protein was prepared from the cultures in RIPA Lysis
287Buffer (CWBio, Beijing, China). After maintaining the sam-
288ples for 20 min on ice, BCA protein assay (Beyotime Biotech,
289Jiangsu, China) was used to determine the protein concen-
290tration. Equal amounts of proteins from SH-SY5Y cells of
291each sample were resolved by SDS-PAGE on 12 % poly-
292acrylamide gels and then electrotransfered to PVDF mem-
293branes (Millipore Corp, USA). After blocking the membranes
294in 5 % non-fat dry milk in Tris-buffered saline with 0.1 %
295Tween 20 (TBST) for 2 h, the membranes were incubated
296with the following primary antibodies at 4 C overnight: anti-
297SOD1 (1:1000, Immunoway, USA), anti-SOD2 (1:500,
298Wanleibio, Liaoning, China), anti-cytochrome c (1:500,
299Wanleibio, Liaoning, China), anti-caspase-9 (1:500, Wan-
300leibio, Liaoning, China), anti-caspase-3 (1:500, Wanleibio,
301Liaoning, China), anti-Bax (1:1000, Wanleibio, Liaoning,
302China), anti-Bcl-2 (1:1000, Wanleibio, Liaoning, China), and
303b-actin (1:500, Immunoway, USA). Then, the membranes
304were washed with TBST five times and incubated with a
305secondary antibody which was conjugated to horseradish
306peroxidase for 2 h at room temperature. Protein bands were
307detected using an enhanced chemiluminescence kit (Bey-
308otime Biotech, Jiangsu, China) and imaged using a Molecular
309Imager ChemiDoc XRS system (Bio-Rad). Signals were
310quantified using densitometric analyses with Quantity One
311analysis software (BioRad), and results are expressed as
312optical density arbitrary units.
313Immunofluorescence
314SH-SY5Y cells were cultured on cover-slips, fixed with
3154 % paraformaldehyde at room temperature for 20 min,
316washed three times with PBS, and finally permeabilized
317with PBS containing 2 % Triton-X100 for 10 min. Cells
318were incubated with the following primary antibodies at
3194 C overnight: Bax (1:150, Immunoway, USA) and Bcl-2
320(1:150, Wanleibio, Liaoning, China). After washing with
321PBS, SH-SY5Y cells were further incubated with the sec-
322ondary antibody conjugated to anti-rabbit Dylight 488
323(1:1000, Abbkine, California, USA) for 2 h. Cell nuclei
324were stained with DAPI for 10 min. Finally, the cover-slips
325were washed and mounted with fluoromount. The cells
326were visualized using an inverted fluorescent microscope
327(Leica, Germany). Median Fluorescence Intensity was
328analyzed using Image J software, and results expressed as
329the arithmetic means of the optical densities (arbitrary




Journal : Large 10571 Dispatch : 28-10-2016 Pages : 12
Article No. : 437
h LE h TYPESET












333 All experiments were conducted at least in triplicate, and
334 representative data are expressed as the mean ± SD. The
335comparisons were evaluated by one-way analysis of vari-
336ance, and for those significant, post-hoc multiple compar-
337isons between means was realized with Turkey test. All
338statistical analyses were performed using SPSS statistics
Fig. 1 OECCM reduces Ab25–35-induced cell death in SH-SY5Y
cells by decreasing apoptosis. Cell viability was analyzed by CCK8 in
control cells (A), Ab25–35-alone-treated SH-SY5Y cells (B), and
Ab25–35 ? OECCM-treated SH-SY5Y cells (C). The results were
compared among control cells (CTRL), Ab25–35-alone-treated SH-
SY5Y cells (Ab), Ab25–35 ? OECCM-treated SH-SY5Y cells
(Ab ? OECCM), Ab25–35 ? heat-inactivated OECCM-treated SH-
SY5Y cells (Ab ? HOECCM), Ab25–35 ? HeLaCM-treated SH-
SY5Y cells (Ab ? HeLaCM), and Ab25–35 ? HEKCM-treated SH-
SY5Y cells (Ab ? HEKCM) (D). Data are expressed as the
mean ± SD (n = 6). *p \ 0.05, ***p \ 0.001, no significance is
indicated as ‘‘NS’’. Scale bar 20 lm. Cell apoptosis was detected by
flow cytometry in control cells (Ea), Ab25–35 alone-treated SH-SY5Y
cells (Eb) and in Ab25–35 ? OECCM-treated SH-SY5Y cells (Ec)
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339 22.0 software, and values of p \ 0.05 were considered to
340 be significant. All graphs were drawn by using the software
341 Graphpad Prism 5.3.
342 Results
343 OECCM Reduces Ab25–35-Induced Cell Death
344 in SH-SY5Y Cells by Decreasing Apoptosis
345 Ab25–35-alone-treated cells displayed shrinkage, round cell
346 body, and smaller body size than normal cells.
347 OECCM ? Ab25–35-treated cells showed similar morphol-
348 ogy to normal cells (Fig. 1A–C). While cell viability for
349 Ab25–35-treated cells was lower than control cells (CTRL),
350 OECCM reduced significantly Ab25–35-induced cell death
351 compared with Ab25–35-alone-treated cells (Fig. 1D).
352Surprisingly, HOECCM also showed similar protective
353effects with OECCM (Fig. 1D). No beneficial potential was
354observed with HeLaCM and HEKCM (Fig. 1D).
355Next we looked at cellular apoptosis in different con-
356ditions, by flow cytometry. In the scatter of the flow
357cytometry results, the lower left quadrant represents normal
358cells (AnnexinV-FITC-/PI-), the lower right quadrant
359represents early apoptotic cells (AnnexinV-FITC?/PI-),
360and the upper right quadrant represents the late apoptotic
361and necrotic cells (AnnexinV-FITC?/PI?)(Jinbo et al.
3622013). Compared with control (Fig. 1Ea), exposure of SH-
363SY5Y cells to Ab25–35 resulted in an increase of cell death
364with approximately 29.9 % of cells in apoptosis (7.1 % in
365the early and 22.8 % in the late apoptotic stage) (Fig. 1Eb).
366Concomitant OECCM treatment reduced Ab25–35-induced
367death resulting in 8.6 % cell apoptosis (3.9 % of early and
3685.4 % of late apoptotic cell) (Fig. 1Ec).
Fig. 2 OECCM decreases ROS generation in SH-SY5Y cells. The
generation of reactive oxygen species was analyzed by flow
cytometry in normal cells (A), Ab25–35-alone-treated SH-SY5Y cells
(B) and Ab25–35 ? OECCM-treated SH-SY5Y cells (C), and the
results were compared across the different treatments (D). Data are
expressed as the mean ± SD of CellROX Fluorescence intensity
(n = 3). E The levels of malondialdehyde (MDA) in the cell
supernatant were measured by a UV–Visible spectrophotometer
(n = 5). *p \ 0.05, no significance is indicated as ‘‘NS’’
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369 OECCM Decreases ROS Generation in SH-SY5Y
370 Cells
371 The accumulation of ROS has been observed in Ab25–35-
372 induced cell toxicity, and mitochondria have been consid-
373 ered to be sensitive targets for ROS (Yang et al. 2016). To
374 determine whether OECCM could decrease the intracellular
375 ROS levels, we used a ROS-sensitive dye, CellROX Orange.
376 Exposure to Ab25–35 resulted in significantly higher ROS
377 levels in SH-SY5Y cells (Fig. 2B) compared with controls
378 (Fig. 2A, D). ROS levels were significantly lower in
379 Ab25–35 ? OECCM-treated SH-SY5Y cells (Fig. 2C, D)
380 than those in cells treated with Ab25–35 alone (Fig. 2B).
381 There was no significant difference of ROS levels between
382 normal cells and the OECCM-treated cells (Fig. 2D).
383 Because oxidative stress has been shown to trigger and
384 sustain the pathogenesis of Ab25–35-induced cell toxicity,
385 we examined whether OECCM treatment decreased
386 oxidative stress induced by Ab25–35. For such purpose, we
387 analyzed lipid peroxidation by determining the MDA level.
388 There is a significant increase of MDA levels in SH-SY5Y
389 cells treated with Ab25–35, relative to non-treated cells.
390These levels return to control conditions in Ab25–35 ?
391OECCM-treated SH-SY5Y cells (Fig. 2E).
392OECCM Modulates the Redox State in SH-SY5Y
393We also investigated whether treatment could restore
394antioxidant status, by determining the enzymatic activities
395and gene expression of SOD, CAT, and GPx. We further
396detected the protein levels of two important anti-oxidative
397enzymes, SOD1 and SOD2.
398Exposure to Ab25–35 resulted in significantly lower
399levels of total SOD, CAT, and GPx enzymatic activities,
400compared with non-treated cells. These activities signifi-
401cantly increase in Ab25–35 ? OECCM-treated SH-SY5Y
402cells (Fig. 3A). After treatment with Ab25–35, the gene
403expression levels (2DDCt ) of SOD1, SOD2, CAT, and GPx
404suffer a significant reduction. Such expression levels are
405partially restored by OECCM, with a significant increase in
406Ab25–35 ? OECCM-treated SH-SY5Y cells relative to
407Ab25–35-treated cells (Fig. 3B). The same conclusion was
408reached when protein levels of SOD1 and SOD2 were
409determined (Fig. 3C, D) by Western Blot.
Fig. 3 OECCM modulates the redox state of SH-SY5Y cells exposed
to Ab25–35. A Enzymatic activities of total SOD (T-SOD), CAT, and
GPx. B mRNA levels of endogenous antioxidant enzyme genes were
detected by q-PCR. The expression of each mRNA was calculated as
2DDCt ; and the mRNA levels of SOD1 and SOD2, CAT, and GPx
were normalized with the mRNA levels of GAPDH. C, D SOD1 and
SOD2 protein levels were detected by Western blot, and were
normalized with the expression level of b-actin. Data are expressed as
mean of arbitrary units ± SD (n = 3). *p \ 0.05, **p \ 0.01,
***p \ 0.001, no significance is indicated as ‘‘NS’’
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410 OECCM Does Not Alter Ca21 Concentration in SH-
411 SY5Y cells
412 Ca2? overload is associated with mitochondrial dysfunction,
413 which contributes to apoptosis. There was no significant dif-
414 ference in intracellular Ca2? concentration among control
415 cells, Ab25–35 -alone-treated cells and Ab25–35 ? OECCM-
416 treated cells, as demonstrated by flow cytometry (Fig. 4A, B).
417 OECCM Prevents the Ab25–35-Induced Activation
418 of the Mitochondria-Mediated Apoptosis Pathway
419 in SH-SY5Y Cells
420 Mitochondria-mediated apoptosis has been suggested to be
421 involved in Ab25–35-induced cell toxicity. We therefore
422 investigated whether the beneficial role of OECCM in
423 preventing Ab25–35-induced SH-SY5Y cell death involved
424 the inhibition of the mitochondria-mediated apoptosis
425 pathway. Mitochondria-mediated apoptosis requires the
426 interplay of a number of pro- and anti-apoptotic B cell
427lymphoma-2 (Bcl-2) family proteins and the caspase cas-
428cade (Soriano and Scorrano 2011). To assess the status of
429the mitochondria-mediated apoptosis pathway, we mea-
430sured the levels of pro-apoptotic molecules cytochrome c,
431caspase-3, caspase-9, and Bax, as well as the anti-apoptotic
432molecule Bcl-2 in SH-SY5Y cells, by q-PCR and Western
433blotting.
434Exposure of cells to Ab25–35 resulted in significantly
435higher mRNA levels of cytochrome c, caspase-9, caspase-
4363, and Bax with respect to control cells (Fig. 5A), as well
437as a protein increase for the same conditions (Fig. 5B, C).
438As expected, lower expression levels of the anti-apoptotic
439Bcl-2 gene (mRNA and protein) were observed in SH-
440SY5Y ? Ab25–35 cells compared with controls (Fig. 5A,
441B). On the contrary, SH-SY5Y cells treated with
442Ab25–3 ? OECCM had significantly lower gene expression
443levels (mRNA and protein) of cytochrome c, caspase-9,
444caspase-3, and Bax than those from cells treated with
445Ab25–35 alone (Fig. 5A–C). pposite results were obtained
446for Bcl-2, for which mRNA and protein levels were sig-
447nificantly higher in Ab25–35 ? OECCM-treated cells than
448those in cells treated with Ab25–35 alone (Fig. 5A–C).
449We also performed immune fluorescence staining of
450pro-apoptotic molecule Bax and anti-apoptotic molecule
451Bcl-2 (Fig. 6A) and quantified mean fluorescence inten-
452sity (MFI) using Image J software (Fig. 6B, C). Expo-
453sure of the cells to Ab25–35 resulted in significantly
454higher MFI level of Bax and lower MIF level of Bcl-2
455in Ab25–35-treated SH-SY5Y cells compared with con-
456trols. The MIF levels of Bax and Bcl-2 in Ab25–35 ?
457OECCM-treated SH-SY5Y cells were significantly lower
458and higher, respectively, than those in the cells treated
459with Ab25–35 alone (Fig. 6A–C).
460In summary, our data demonstrate that OECCM treat-
461ment resulted in a 42.55 % improvement in all parameters
462tested compared to those in cells treated with Ab25–35
463alone, OECCM treatment resulted in 77.41 % restoration
464in all parameters tested compared to those in control
465untreated cells, and Ab25–35 resulted in a 64.77 % deteri-
466oration in all parameters tested compared to those in con-
467trol cells (Supplementary Table 2).
468Discussion
469AD, a neurodegenerative disease associated with aging, is
470considered to be the most common form of dementia. The
471cause of AD involves the accumulation of Ab, oxidative
472stress, inflammation, and dysfunction in several processes
473including hormonal and mitochondrial pathways (Do-
474raiswamy 2002). The increased proteolytic degradation of
475APP and aggregation and deposition of Ab are considered
476to be two characteristic pathologies in the development and
Fig. 4 OECCM does not alter Ca2? concentration in SH-SY5Y cells.
[Ca2?] was analyzed using Ca2? imaging in control cells, Ab25–35-
alone-treated SH-SY5Y cells, and Ab25–35 ? OECCM-treated SH-
SY5Y cells (A). The results were compared between different
treatments (B). Data are expressed as the mean ± SD (n = 3). No
significance is indicated as ‘‘NS’’
Cell Mol Neurobiol
123
Journal : Large 10571 Dispatch : 28-10-2016 Pages : 12
Article No. : 437
h LE h TYPESET











477 progression of AD (Tsunekawa et al. 2008). Ab plays a role
478 in synaptic dysfunction and neuronal death and therefore
479 contributes to cognitive impairment (Roher et al. 2009).
480 Specifically, Ab25–35 is the core toxic fragment of the
481 full-length Ab peptide (Yang et al. 2016) and can permeate
482 through the cell membrane relatively more easily due to its
483 smaller size. In addition, its toxicity is similar to those of
484 Ab1–40 and Ab1–42 (Mattson et al. 1997). More impor-
485 tantly, Ab25–35 is a particularly intractable peptide because
486 it aggregates rapidly, unlike the full-length Ab, which
487 requires aging for more than 1 week before it aggregates
488 and becomes toxic (Hughes et al. 2000). As such, it is often
489 used for in vitro studies of the neuroprotective effects of
490 various drugs predicted to modulate Ab toxicity (Yu et al.
491 2014).
492 It is reported that OECCM is able to promote the sur-
493 vival and the neurite outgrowth of hippocampal neurons
494 in vitro (Pellitteri et al. 2009), and it has the capacity to
495 protect SH-SY5Y damage induced by 6OHDA (Shukla
496et al. 2014) and astrocyte damage induced by H2O2 (Jinbo
497et al. 2013; Liu et al. 2013). Furthermore, OECCM further
498increased the differentiation function of neural progenitor
499cells (Carvalho et al. 2014) and human mesenchymal stem
500cells (Zeng et al. 2013) into oligodendrocytes and neurons,
501respectively. As OEC-conditioned media are a source of
502growth factors, we believed that these positive beneficial
503biological effects of OECCM may be mediated by some
504protein/s in a paracrine manner (Woodhall et al. 2001).
505Surprisingly, in the present study, we found that heat-in-
506activated OECCM presented a similar level of protective
507potential compared with OECCM. Thus, the beneficial
508effects of OECCM for SH-SY5Y cells exposed to Ab25–35
509may be brought out through peptide/s or heat-resistant
510protein/s (Kim et al. 2000). Alternatively, it may be the
511effect of molecules protected from heat inactivation inside
512lipidic vesicles, for example, exosomes (Nafar et al. 2015;
513Martı́n-Duque P. personal communication). Further studies
514are needed to address this issue.
Fig. 5 OECCM prevents the
Ab25–35-induced activation of
the mitochondria-mediated
apoptosis pathway in SH-SY5Y
cells. A mRNA levels of
mitochondrial apoptotic-related
molecules were examined by
q-PCR—cytochrome c, caspase-
9, caspase-3, Bax, and Bcl-2—
and were normalized to the
expression level of GAPDH.
Data are expressed as the
mean ± SD (n = 3). *p \ 0.05,
***p \ 0.001; no significance is
indicated as ‘‘NS’’. B, C Protein
levels of cytochrome c, caspase-
9, caspase-3, Bax, and Bcl-2
were examined by western blot
and were normalized to the
expression level of b-actin. Data
are expressed as the
mean ± SD (n = 3). *p \ 0.05,
**p \ 0.01, ***p \ 0.001; no
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515 The generation of ROS leading to oxidative damage and
516 neuronal cell death plays an important role in the patho-
517 genesis of neurodegenerative disorders, and antioxidants
518 have been proposed to protect against Ab25–35-induced
519 toxicity in AD (Jung Choi et al. 2009). Lipid peroxidation
520 and antioxidant activities of SOD enzymes in brain tissue
521 from patients with AD and age-matched controls, were
522 determined in different brain regions: SOD activity was
523 significantly decreased in frontal and temporal cortex of
524 AD (Marcus et al. 1998). In the present study, ROS pro-
525 duction increased after Ab25–35 exposure and decreased
526 after OECCM treatment. Ab25–35 exposure resulted in
527 reduction of mRNA levels of SOD1, SOD2, GPx, and
528 CAT; protein levels of SOD1 and SOD2; and activities of
529 total SOD, CAT, and GPx in SH-SY5Y cells. Interestingly,
530 OECCM restored normal levels of antioxidant enzymes
531 system. This observation indicates a positive feedback loop
532in the antioxidant enzymes system of SH-SY5Y cells,
533being activated by OECCM in response to Ab25–35.
534Mitochondrial dysfunction has been correlated to AD,
535its main factors being altered energy metabolism and ROS
536production (Moreira et al. 2010; Lin and Beal 2006). Ab
537could elevate oxidative stress and induce apoptotic cell
538death by initiating mitochondrial dysfunction, which is
539associated with changes in proteins of Bcl-2 family, release
540of cytochrome c, and activation of caspase-3 (Butterfield
541et al. 2013). In the present study, we used q-PCR and
542Western blot to measure the RNA and protein levels of
543mitochondria-mediated apoptosis markers. We found that
544Ab25–35 increased the expressions at mRNA and protein
545levels of cytochrome c, caspase-3, caspase-9, and Bax, and
546decreased mRNA and protein levels of protective Bcl-2.
547Ab25–35 ? OECCM-treated cells partially recovered
548expression levels of mitochondria-mediated apoptosis
Fig. 6 OECCM reverts the Ab25–35-induced activation of the pro-
apoptotic molecule Bax and inhibition of anti-apoptotic molecule Bcl-
2 in SH-SY5Y cells. The pro-apoptotic molecule Bax and anti-
apoptotic molecule Bcl-2 were also examined by immunofluorescence
staining (A), and their median fluorescence intensity (MFI) was
analyzed by Image J software (B and C). Data are expressed as the
mean ± SD (n = 10). ***p \ 0.001, no significance is indicated as
‘‘NS’’. Scale bar 20 lm
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549 markers, indicating that OECCM prevented Ab25–35-in-
550 duced SH-SY5Y cell death through inhibition of mito-
551 chondrial apoptosis pathway.
552 In summary, we have demonstrated that OECCM ame-
553 liorated Ab25–35-induced oxidative damage in neuroblas-
554 toma SH-SY5Y cells through inhibition of the mitochondria-
555 dependent pathway and provided new insights into the
556 paracrine actions of OECs in oxidative stress-induced cell
557 damage. To the best of our knowledge, this is the first study to
558 evaluate and highlight the protective action of OEC against
559 Ab25–35-induced cell insult.
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